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factors, potentially related with the mentioned respiratory diseases prevalence, 
as age, sex, smoking habits were analyzed. Four groups were compared: 1) asthma 
patients, 2) COPD patients, 3) patients with other chronic conditions, and 4) global 
Spanish population. Results: Data from 21,007 adults was recorded. Prevalence 
of asthma was slightly above COPD (5.4% vs 4.7%), and 47.2% were suffering from 
chronic diseases. Asthma patients were younger than those with COPD (51y vs 
61y, as an average, respectively). Concerning EQ-5D results, the dimensions mainly 
affected either in COPD or asthma were, respectively, pain/discomfort (53.7% / 
38.7%), mobility (42% / 27.4%), usual activities (34.4% / 21.8%), and depression/anxi-
ety (32.4% / 25.4%). Based on the EQ-5D questionnaire, the QALYs calculation were 
0.75 for COPD and 0.90 for asthma patients, the latter results were similar to the 
other chronic conditions and to the global population. Health resources in COPD 
patients were significantly higher than in the other 3 groups analyzed, considering 
office visits (GPs/Specialists), hospitalization and emergency unit visits during the 
last year. ConClusions: Patients diagnosed with asthma have a similar HRQOL 
compared to the rest of the population, but COPD patients have it worse. COPD 
is also associated with a higher health resources consumption, which implies a 
relevant impact on the Spanish National Health System.
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objeCtives: As young students are more prone to smoking and associated dan-
gers it affects their health related quality of life (HRQoL). This study was done to 
assess the HRQoL and other associated factors affecting HRQoL among smokers 
and non-smokers who are students. Methods: In this exploratory study a pilot 
tested questionnaire was used to collect information regarding young students, 
demographics, BMI, food habits, alcohol consumption, family history of smoking 
as well as family history of diseases. For health related quality of life measurement 
both descriptive and visual analogue score (VAS) of EQ 5D 5L questionnaire ware 
used. The data collected was analyzed using SPSS 16.0.0. The test of significance 
was done by using Chi Square test for checking the associated habits and Mann 
Whitney U test is done to check the significance of association between HRQoL 
and smoking and other associated habits. Results: Total 126 students were 
included in the study. The age was 22.9±2.17 (Mean±SD) and BMI was 22.03±4.27 
(Mean±SD) and all of them were residing in an University town. 63 % of the stu-
dents were non-vegetarians and 44.8% were consuming alcohol at least once 
in a month. The mean EQ 5D visual analogue score of the studied population 
was found to be 83.3±11.5 (Mean±SD). The Chi square test showed the associa-
tion between smoking with family history of smoking, alcohol consumption and 
soft drinks consumption (p< 0.001, 0.001 and 0.05 respectively). Mann Whitney 
U test showed as significant difference in the VAS scores among smokers and 
non-smokers (p< 0.05). ConClusions: Health Related Quality of Life is severely 
compromised by smoking, hence there is an urgent need to create awareness 
among young students.
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objeCtives: The aim of this study is to evaluate the health related quality of life 
(HRQoL) and health care utilization in primary care (PC) patients with asthma 
treated with beclomethasone/formoterol. Methods: This study analyzed the 
HRQoL and health care utilization from a cohort of 65 patients over 6 months. 
Inclusion criteria were patients aged 18 years and older with moderate/severe per-
sistent asthma (GINA criteria) treated with beclomethasone/formoterol at least 1-3 
months before the inclusion in the study. Sociodemographic variables such as age, 
sex, duration of disease, severity of asthma, concomitant pathology were evalu-
ated. The evaluation of the HRQoL were measured with the Asthma Quality of Life 
Questionnaire (AQLQ), and two generic questionnaires, EuroQol-5D and SF-36. The 
evaluation of the health care utilization included visits to PC, visits of care nursing 
and visits to accident and emergency (A&E) department and admissions. Statistical 
analysis: average ± standard deviation (SD); frequency and proportions. Inferential 
statistics in terms of average HRQoL and health care utilization were calculated 
using T-Student, Chi-square and ANOVA. Results: Average patients were female 
(60%), aged 49 years old (SD 2.16) with disease duration of 92 months (SD 18.34). 
The average health care utilization was: 3.43 (SD 0.35) visits to PC and 1.42 (SD 
0.29) visits to nursing; analytical: 0.63 (SD 0.09); chest x-ray: 0.38 (± 0.08); ECG 0.32 
(SD 0.08). The average of exacerbations without hospital admission was 1.09 (SD 
0.19) and the A&E department visits of PC related with asthma was 0.43 (SD 0.11). 
Statistically significant differences (p < 0.05) and clinically significant between the 
beginning and end of the study on all forms of quality of life measured in these 
patients were found measured with AQLQ, EuroQol-5D and SF36. ConClusions: 
Beclomethasone/formoterol improved HRQOL in patients with asthma representing 
a good cost/utility relationship.
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objeCtives: The aim of this study was to assess impairment in health-related 
quality of life (HRQoL) of pulmonary tuberculosis (PTB) patients in Pakistan. This 
study also evaluated utility of various socio-demographic and clinical factors that 
it was easy to use, the screens were easy to read, and that they could sign on and 
move through the questions with no difficulty. Subjects from the Spanish-speaking 
countries had the lowest reported difficulty turning the device on, with higher 
levels of difficulty observed by the interviewers in China, who reported “somewhat” 
for two of the three respondents. Interviewers observed that the majority (n= 15) 
could “easily” or “very easily” use the device. ConClusions: Given the consistent 
ease-of-use findings in these diverse, device naïve subjects across 7 countries and 
the emphasis on subject training in clinical trials, it was determined that usability 
testing with future translations was unnecessary.
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objeCtives: The Nighttime Symptoms of COPD Instrument (NiSCI), developed 
through qualitative research with patients, includes six symptom items: cough-
ing, wheezing, shortness of breath, difficulty bringing up phlegm, chest conges-
tion, and tightness in the chest. A symptom severity score is computed based on 
these items. In situations where patient burden is a major consideration, a smaller 
set of items may be preferable. Clinicians identified coughing, wheezing, short-
ness of breath, and difficulty bringing up phlegm as the most relevant for COPD 
patients. Exploratory psychometric analyses were conducted for the symptom sum-
mary score based on these four items compared with all six items. Methods: 
Psychometric properties of the four-item versus six-item symptom summary scores 
were examined using phase 3 clinical trial data from a random split-half sample. 
Symptom summary scores were tested for: internal consistency using Cronbach’s 
Alpha; test-retest reliability using Intraclass Correlation Coefficients (ICC) and 
Concordance Correlation Coefficients (CCC); convergent validity using Spearman 
Rank Order Correlation Coefficients; and known-groups validity using ANOVA and 
Scheffe’s test for pair-wise comparisons. Results: Patients (n= 832) were aged 40–93 
years (mean 63.78 ±-9.07 [SD]) and 51% were male. Both scores were internally 
consistent and valid. Cronbach’s alpha was slightly higher for the six-item symp-
tom summary (0.85) versus the four-item symptom summary (0.78). ICC and CCC 
scores were 0.85 for the six-item and 0.84 for the four-item symptom summary 
scores. Likewise, construct validity and known-groups validity were similar for both 
scores (p> 0.05). ConClusions: The NiSCI symptom summary score based on four 
items has similar psychometric properties to the six-item symptom summary score. 
Both scores have measurement properties suitable for use in clinical trials. Further 
work will test the psychometric properties of the instrument administered with 
four items.
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objeCtives: Idiopathic pulmonary fibrosis (IPF) is a progressive disease charac-
terized by declining lung function, leading to debilitating limitations on activity 
which may negatively impact HRQOL. However, HRQOL data in this population 
are limited. The primary objective was to evaluate HRQOL in IPF using measures 
from the Patient Reported Outcomes Measurement Information System (PROMIS). 
The secondary objective was to examine the association between key symptoms 
and HRQOL. Methods: Individuals with IPF were recruited via patient advocacy 
organizations to complete an online survey consisting of PROMIS-29 health pro-
file, PROMIS-Dyspnea, dyspnea measured by Modified Medical Research Council 
Dyspnea Scale (MMRC), self-reported cough, and cough subscale of the ATAQ 
(A Tool to Assess Quality of life)-IPF. PROMIS-29 scores have mean= 50, SD= 10 in the 
US general population; PROMIS-Dyspnea scores are referenced to a chronic obstruc-
tive pulmonary disease (COPD) sample. Results: The 275 survey participants 
showed worse mean PROMIS-29 scores than the general population in all meas-
ured domains (mean value: anxiety= 63.9; depression= 61.9; fatigue= 60.1; pain= 62.6; 
sleep disturbance= 55.8; physical function= 36.2; social role= 42.2). Dyspnea severity 
was associated with worse mean PROMIS-29 scores (all p< 0.05). PROMIS-Dyspnea 
(mean= 58.7) and Functional Limitations Due to Dyspnea (mean= 58.4) scores were 
worse than the COPD reference population. Cough severity was associated with 
worse HRQOL measured by ATAQ-IPF. Reliability of PROMIS-29 scores exceeded 0.65 
and were moderately correlated with measures of similar constructs. A limitation 
of the study is that data drawn from a sample from advocacy organizations might 
not be generalizable to the entire IPF population. ConClusions: Patients with IPF 
report substantial deficits in HRQOL, particularly with respect to physical function, 
anxiety, pain, depression and fatigue. Patients suffering from dyspnea and cough 
had poorer HRQOL. These deficits should be monitored in clinical practice and 
evaluated in investigational trials aiming to improve the HRQOL of IPF patients.
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objeCtives: To analyze the impact that asthma and chronic obstructive pulmo-
nary disease (COPD) have on patients Health Related Quality of Life (HRQOL) and 
on health resources consumed by the Spanish Health System. Methods: Data 
obtained from the last Spanish National Health Survey (SNSHS) 2011-12, on adult 
population (> 15y), identifying patients with a diagnostic of asthma or COPD. 
Descriptive statistic analysis was carried out, specially focused on self-reported 
HRQOL (EQ-5D-5L) and health resources utilization. The EQ-5D results were trans-
lated into QALYs, with the social tariffs validated in Spain. Other demographic 
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patients recruited through an agency, Twitter and Asthma UK’s website. Participants 
had experienced a NCS and a SS < 3 years previously. Medication history and Asthma 
Control Test (ACT) scores were collected. Interviews were audio-recorded, and the-
matically analysed. Results: The sample was 69% Caucasian, with six males and 
seven females, and a mean age= 47. Most were working full time or retired, and had 
many years since asthma diagnosis (mean= 22 years). NCS were related to reliever 
(n= 7), preventer (n= 4) or both (n= 2) medications with the most common NCS from 
one brand to another (n= 4). Participants reported negative feelings, difficulty using 
the medication and ineffective symptom control. Most participants used the NCS 
medication < 6 months (range < 24 hours–2 years). The SS for most was a return to 
their original pre-NCS medication (n= 11). Although most found getting their SS 
straightforward, this required at least two HCP visits for half the sample, and took 
up to two months to obtain. Most expected symptoms to improve following the SS 
but nine participants still had sub-optimal ACT scores. Lasting impacts included 
damaged relationships with HCPs, strong views about NCS and concern about NCS 
reoccurrence. ConClusions: Failure to inform and involve patients in medication 
changes can have lasting impacts. It is important to note that NCS can incur costs 
associated with rejection of medicines and additional consultations, thus negating 
any attempt at cost saving.
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objeCtives: To evaluate the degree to which the officially pre-determined cost 
and average length of stay (ALoS) per selected KEN-DRG reflect actual resource 
use and to investigate other factors (e. g. size, type and location of hospital) corre-
lated with charges and ALoS. Methods: Data were from the Health Regions data 
base and included discharges, ALoS, and charges in NHS Hospitals for the selected 
KEN-DRGs. Predetermined ALoS and cost per KEN-DRG were derived from Gazette 
946/27/03/2012. Continuous variables did not follow normal distribution, so non 
parametric methods (Spearman’s correlation coefficient, Kruskal-Wallis test and 
Mann-Whitney test) were used. A two sided p-value ≤ 0.05 was considered statis-
tically significant. Results: Higher length of stay compared with the officially 
pre-determined was found for Chronic Obstructive Pulmonary Disease (COPD) 
with complications (10.8 vs 9 days), Bronchitis & Asthma with complications (5.8 
vs 4 days), Bronchitis & Asthma without complications (2.7 vs 2 days) and Breast 
Cancer with complications (7.9 vs 5 days). Consequently, officially pre-determined 
cost for Breast Cancer with complications (€ 965), Bronchitis & Asthma with com-
plications (€ 792) and COPD with complications (€ 1,446) represents less than 90% 
of total hospital charges (total actual average charge: € 1,186; € 929; € 1,634 respec-
tively). However, for the rest of the DRGs, under study, there were none or limited 
additional hospital charges. For all KEN-DRGs, size and population density was 
positively correlated with total charges (rs= 0.12, p= 0.018; median for Athens = 863 
& semi-urban= 752 p= 0.09 respectively). Moreover, for Bronchitis & Asthma with and 
without complications, population density was found to be positively correlated 
with ALoS (median for urban areas= 5.1 and semi-urban= 4.7; p= 0.09 and median 
for urban areas= 3 and semi-urban= 2.5; p= 0.03 respectively). ConClusions: The 
introduction of KEN-DRGs was a useful first step to modernize the hospital reim-
bursement system. However, further revisions are required in order for KEN-DRGs 
to become more useful.
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objeCtives: Asthma is under-diagnosed and under-treated in elderly, and utili-
zation of asthma medications in this population is not well characterized. This 
study describes utilization patterns of asthma medications in newly diagnosed 
≥ 50 patients. Methods: Medicare enrollees are followed for 12 months after first 
asthma diagnosis between Q1 2004- Q3 2012 (ICD-9-CM code: 493*). Treatment pat-
tern analysis was applied to initiators of asthma medications. Patients with > 1 
prescription of second-line therapy following exposure to first-line therapy are con-
sidered therapy switchers or augmenters. Patients with history of chronic obstruc-
tive pulmonary disease are excluded (ICD-9-CM codes: 490, 491*, 492*, 494*, 495* 
& 496). Results: Among 126,176 elderlies with asthma, 24,021 initiated asthma 
therapy within 12 months of asthma diagnosis (70% women, median age 70 years). 
319 (1.3%) continued therapy with one drug class (first-line therapy); 13,940 (58%) 
discontinued first-line therapy; 3,469 (14.4%) switched to another drug class (sec-
ond-line therapy); and 6,293 (26.2%) added second-line therapy (augmented). About 
34% of patients initiated therapy with inhaled short-acting beta-agonists (SABA); 
majority of them either discontinued SABA or added a controller medication. 19% 
of elderly patients started with oral corticosteroids after asthma diagnosis, 77% 
discontinued them and 12% switched to another asthma controller. Among con-
troller medications, inhaled corticosteroids (ICS) /long-acting beta-agonists (LABA) 
combination therapy, ICS monotherapy, and leukotriene antagonists respectively 
accounted for 19%, 12%, and 11% of treatment initiators. The majority of these anti-
are directly and indirectly linked with HRQoL of TB patients. Methods: A prospec-
tive cross-sectional study was conducted at a tertiary care hospital in a province 
of Pakistan, the Punjab. Data was collected by using WHOQOL-BREF question-
naire (Urdu version, pretested for reliability and validity) by means of face-to-face 
interviews and where possible by gender-based focus group sessions. In addition, 
facilitators also used few open-ended questions in order to get patients’ demo-
graphic and socioeconomic data. Participants were also asked to share their per-
sonal experiences of being diagnosed and treated with TB and what impact it had 
on their life style. All obtained data were analyzed using descriptive and inferen-
tial statistics. Results: The overall Cronbach’s alpha coefficient of the revalidated 
WHOQOL-BREF questionnaire was 0.785. The confirmatory factor analysis also pro-
vided an acceptable fit to a four-factor model in the studied sample. The scores for 
negative feelings, blue mood, depression, living place, personal relationships and 
sex life were significantly different in the psychological health and social relations 
domains. Age, gender and physical exercise were also significantly associated with 
the HRQoL of the patients. ConClusions: The WHOQOL-BREF was reliable and 
valid in the assessment of the HRQoL of TB patients in Pakistan. Despite the ability 
to cure TB, there was a significant impact on HRQoL of the TB patients. Till today, 
much attention is spent on curative and preventative mechanisms whereas the 
impact of TB on HRQoL is often neglected.
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objeCtives: To assess published data on perennial allergic rhinitis/house dust 
mite allergic (PAR) patients and seasonal allergic rhinitis/grass pollen allergic (SAR) 
patients in order to establish the burden of allergic rhinitis (AR) and allergic asthma 
from both a quality of life (QoL) and cost perspective. Methods: A systematic liter-
ature review was conducted using Medline and Embase in eight pre-specified coun-
tries for the time period of January 2000 to January 2014. Search terms were related 
to QoL and/or cost. A total of 2963 abstracts and titles were identified. 50 abstracts 
met predefined criteria and provided data for calculations and collation. Results: 
Based on the RQLQ, the overall QoL of PAR patients was significantly worse than that 
of SAR patients (2.73 ± 0.12 cf. 2.04 ± 0.18, p≤ 0.001). In general, practical problems 
(mean: 3.80 ± SE: 0.08) and activities (mean: 3.70 ± SE: 0.11) were the most affected 
domains. Measured by the physical component score from the SF-36 questionnaire, 
the overall QoL of PAR patients was worse (p= 0.002) than that of SAR patients (49.06 
± 1.26 cf. 64.19 ± 7.89). For both PAR and SAR patients, domains measured by the 
SF-36 showed that vitality (mean: 59.95 ± SE: 3.24) was the most affected domain. 
Based on RQLQ, allergy immunotherapy improves eye symptoms, nasal symptoms, 
activities and practical problems the most in grass allergic patients. Direct compari-
son of total direct and indirect costs was complicated by differences in individual 
costs assessed among studies, however, the primary burden of costs is indirect 
and caused by high absenteeism and presenteeism. ConClusions: The QoL and 
economic burden of AR was substantial in the countries included in this review. 
However, limitations regarding the number of studies per country, heterogeneity 
between studies, and the lack of presented data have restricted the conclusions 
that could be drawn.
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objeCtives: To determine the Quality of Life (QoL) of bronchial asthma patients in 
a tertiary care teaching hospital at baseline and at follow up. Methods: The study 
was conducted for a period of 6 months among 100 bronchial asthma patients, with 
and without co-morbidities, admitted to the pulmonary and medicine wards in 
the university hospital after obtaining the ethical clearance. The quality of life was 
assessed using Asthma Quality Of life Questionnaire (AQLQ). Patients were followed 
up after 4weeks from the date of discharge. Statistical analysis was performed using 
SPSS version 20. Results: The mean age of the study population was 53.30±14.59 
having 61% of the patients as females. Data was analyzed by Wilcoxon signed rank 
test. The total score of Qol at follow up (5.94 ±0.76) showed an improvement with 
a P value < 0.0001 (wilcoxon signed rank t test) when compared with baseline (3.92 
± 1.04). A significant improvement in symptoms was seen at follow up (6.05 ± 0.82) 
from baseline (3.93 ± 1.14). The activity limitation improved with a P value < 0.0001 
(Wilcoxon signed rank t test) from baseline (4.00 ± 1.08) to follow up (5.92 ± 0.83). At 
follow up (5.97 ± 0.82) the emotional function showed an enhancement on compar-
ing with baseline (3.92 ± 1.14). The environmental stimuli showed no significant 
changes at baseline (3.66 ± 1.29) and follow up (3.84 ± 1.34). ConClusions: The 
results of the study suggests that clinical pharmacists have a major role in improv-
ing patient knowledge and thereby significantly improve the quality of life of the 
patient.
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objeCtives: Patient satisfaction with asthma treatment is associated with bet-
ter adherence and achievement of treatment goals. While medication changes are 
sometimes instigated for clinical or financial reasons, changes without patients’ 
knowledge or involvement (‘non-consented switch’ [NCS]) can impact symptom 
control and patient-health care provider (HCP) relationships. This study explored 
experiences of patients who had a NCS and subsequently requested and received a 
second switch (SS). Methods: Interviews were conducted with 13 UK adult asthma 
